An open trial of MAO inhibitors in bulimia.
Twelve bulimic women with prominent depression and anxiety were treated with monoamine oxidase inhibitors (MAOIs). A dramatic response was seen in 10 cases. The implications of this open clinical trial for the understanding and treatment of bulimia are discussed.
D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy / Q000523:psychology; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy* / Q000523:psychology; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010624:Phenelzine / Q000627:therapeutic use; D014191:Tranylcypromine / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D010624:Phenelzine